BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Catamaran Bio Announces Scientific Advisory Board

  Catamaran Bio, Inc. today announced the formation of its scientific advisory board (SAB).

  October 26, 2021

   · 

  6 min read
• Business

  AVROBIO Announces the Appointment of Essra Ridha, M.D., MRCP, FFPM, as Chief Medical Officer

  AVROBIO, Inc. today announced the appointment of Essra Ridha, M.D., MRCP, FFPM, as chief medical officer.

  October 26, 2021

   · 

  7 min read
• BioMidwest

  Curative Potential for Diabetes, Alzheimer’s and Parkinson’s Seen in Research Data Highlighted at Neurodon’s 2nd Annual Scientific Advisory Board Meeting

  Curative Potential for Diabetes, Alzheimer’s and Parkinson’s Seen in Research Data Highlighted at Neurodon’s 2nd Annual Scientific Advisory Board Meeting

  October 26, 2021

   · 

  3 min read
• Business

  Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance

  Novozymes delivered 7% organic sales growth in the third quarter and 6% organic sales growth in the first nine months of 2021.

  October 26, 2021

   · 

  3 min read
• Mindset Pharma to Participate in Wonderland: Miami on November 8-9, 2021

  Mindset Pharma Inc. today announced that it will participate in Microdose’s Wonderland: Miami to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 8-9

  October 26, 2021

   · 

  2 min read
• Business

  Aptose to Report Third Quarter 2021 Financial Results and Hold Conference Call on Thursday, November 11, 2021

  Aptose Biosciences Inc. will report financial results for the quarter ended September 30, 2021, and provide a corporate update on Thursday, November 11, 2021, after the close of the market.

  October 26, 2021

   · 

  2 min read
• Deals

  Progenity Reduces Outstanding Debt by $20.175 Million Through a Private Exchange of $20.175 Million of Its 7.25% Convertible Senior Notes Due 2025 for Shares of Common Stock

  Progenity Reduces Outstanding Debt by $20.175 Million Through a Private Exchange of $20.175 Million of Its 7.25% Convertible Senior Notes Due 2025 for Shares of Common Stock

  October 26, 2021

   · 

  4 min read
• Pharm Country

  ContraFect to Present Data on the Potential of DLAs to Treat Pulmonary Infections in Cystic Fibrosis Patients

  ContraFect Corporation today announces it will be presenting a poster on the activity of DLAs against common Gram-negative pathogens responsible for pulmonary infections in Cystic Fibrosis patients at the North American Cystic Fibrosis Conference, which will be held virtually from November 2-5, 2021.

  October 26, 2021

   · 

  5 min read
• Business

  InMode Reports Record Third Quarter 2021 Financial Results: Quarterly Revenue of $94.2M, 58% Year-Over-Year Growth; GAAP Net Income of $44.7M, 87% increase compared to Q3 2020

  InMode Ltd. today announced its consolidated financial results for the third quarter ended September 30, 2021 .

  October 26, 2021

   · 

  18 min read
• Enveric Biosciences to Participate in Wonderland: Miami Conference

  Enveric Biosciences today announced that Dr. Joseph Tucker , Chief Executive Officer of Enveric Biosciences, will participate in the upcoming Wonderland: Miami conference:

  October 26, 2021

   · 

  1 min read